Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Multi-modal proteomic characterization of lysosomal function and proteostasis in progranulin-deficient neurons

WADE-MARTINS R., (2023), Molecular Neurodegeneration, 18

Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson’s

BRIMBLECOMBE K. et al, (2023), European Journal of Neuroscience

Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application

Maheshwari S. et al, (2023), Translational Neurodegeneration, 12

C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9

Vahsen B. et al, (2023), Nature Communications

Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson's disease models.

Williamson MG. et al, (2023), Hum Mol Genet

Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson’s iPSC-dopamine neurons

Beccano-Kelly DA. et al, (2023), iScience, 107044 - 107044

Impaired dopamine release in Parkinson’s disease

Cramb KML. et al, (2023), Brain

Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson’s disease GBA-N370S dopamine neurons

RYAN B., (2023), Cell Reports

Early striatal hyperexcitability in anin vitrohuman striatal microcircuit model carrying the Parkinson’sGBA-N370Smutation

Do Q. et al, (2023)

Identification of a possible proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSF

WINCHESTER L. and NEVADO-HOLGADO A., (2022), Brain Communications

Multiparameter phenotypic screening for endogenous TFEB and TFE3 translocation identifies novel chemical series modulating lysosome function.

Carling PJ. et al, (2022), Autophagy, 1 - 14

Pathogenic LRRK2 regulates centrosome cohesion via Rab10/RILPL1-mediated CDK5RAP2 displacement.

Fdez E. et al, (2022), iScience, 25

Hyperexcitability in young iPSC-derived C9ORF72 mutant motor neurons is associated with increased intracellular calcium release.

Burley S. et al, (2022), Sci Rep, 12

Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerability.

Ng B. et al, (2022), Brain Commun, 4

Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism.

Ng J. et al, (2021), Sci Transl Med, 13

REST protects dopaminergic neurons from mitochondrial and α-synuclein oligomer pathology in an alpha synuclein overexpressing BAC-transgenic mouse model.

Ryan BJ. et al, (2021), J Neurosci

Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease.

Bengoa-Vergniory N. et al, (2021), Acta Neuropathol Commun, 9

Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells.

Vilema-Enríquez G. et al, (2020), J Biol Chem, 295, 17973 - 17985

A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders

Agarwal D. et al, (2020), Nature Communications, 11

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease

BENGOA-VERGNIORY N. et al, (2020), Nature Communications

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?